Variant report

Variant	rs10945953
Chromosome Location	chr6:164507526-164507527
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	MAX	chr6:164507086-164507733	K562	blood:	n/a	chr6:164507253-164507266 chr6:164507255-164507265 chr6:164507253-164507266 chr6:164507251-164507266 chr6:164507253-164507268
2	MAX	chr6:164507241-164507582	K562	blood:	n/a	chr6:164507253-164507266 chr6:164507255-164507265 chr6:164507253-164507266 chr6:164507251-164507266 chr6:164507253-164507268
3	ELF1	chr6:164507274-164507588	K562	blood:	n/a	chr6:164507418-164507431
4	MYC	chr6:164507357-164507606	K562	blood:	n/a	n/a

Variant related genes	Relation type
ENSG00000260422	TF binding region

Extended variants
information (count: 15 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:10)

rs_ID	r²[population]
rs10455932	0.96[YRI][hapmap]
rs10484511	0.89[AFR][1000 genomes];0.95[ASN][1000 genomes]
rs10945955	0.90[ASN][1000 genomes]
rs12333017	1.00[CHB][hapmap];1.00[JPT][hapmap]
rs16896107	0.83[AMR][1000 genomes];0.92[EUR][1000 genomes]
rs206701	0.82[CHB][hapmap]
rs9346992	0.92[YRI][hapmap]
rs9456928	0.83[CEU][hapmap]
rs9458980	0.96[AFR][1000 genomes];0.92[ASN][1000 genomes]
rs9458981	0.84[AFR][1000 genomes];0.90[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1018860	chr6:163939347-164532579	Flanking Active TSS Enhancers Weak transcription ZNF genes & repeats Active TSS Genic enhancers Strong transcription Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases
2	nsv538526	chr6:163939347-164532579	Weak transcription Enhancers Active TSS Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Strong transcription Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases
3	nsv1026707	chr6:164188210-164749206	Enhancers Weak transcription ZNF genes & repeats Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA	9 gene(s)	inside rSNPs	diseases
4	nsv538527	chr6:164188210-164749206	Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA	9 gene(s)	inside rSNPs	diseases
5	nsv1029952	chr6:164463355-165268911	Enhancers Weak transcription Flanking Active TSS Active TSS ZNF genes & repeats Bivalent Enhancer Genic enhancers Strong transcription Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	10 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:34 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:164504800-164508000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr6:164504800-164508000	Enhancers	Fetal Muscle Trunk	muscle
3	chr6:164505200-164507600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
4	chr6:164505200-164507600	Enhancers	Fetal Heart	heart
5	chr6:164505200-164507800	Enhancers	Fetal Muscle Leg	muscle
6	chr6:164505200-164507800	Enhancers	Left Ventricle	heart
7	chr6:164505400-164507800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
8	chr6:164505800-164507600	Enhancers	HSMM	muscle
9	chr6:164506000-164507600	Active TSS	Brain Substantia Nigra	brain
10	chr6:164506400-164507600	Weak transcription	Right Ventricle	heart
11	chr6:164506400-164530200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
12	chr6:164506600-164508000	Enhancers	Primary hematopoietic stem cells	blood
13	chr6:164507000-164507600	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr6:164507000-164507800	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
15	chr6:164507000-164519200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
16	chr6:164507200-164507600	Enhancers	Psoas Muscle	Psoas
17	chr6:164507200-164507800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
18	chr6:164507200-164508000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
19	chr6:164507200-164508000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
20	chr6:164507200-164508200	Enhancers	Lung	lung
21	chr6:164507200-164508400	Enhancers	Cortex derived primary cultured neurospheres	brain
22	chr6:164507200-164508400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
23	chr6:164507400-164507600	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
24	chr6:164507400-164507600	Enhancers	Adipose Nuclei	Adipose
25	chr6:164507400-164507600	Enhancers	Brain Hippocampus Middle	brain
26	chr6:164507400-164507600	Enhancers	Skeletal Muscle Male	skeletal muscle
27	chr6:164507400-164507600	Enhancers	Skeletal Muscle Female	skeletal muscle
28	chr6:164507400-164507600	Enhancers	NH-A	brain
29	chr6:164507400-164508000	Enhancers	Brain Inferior Temporal Lobe	brain
30	chr6:164507400-164508400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
31	chr6:164507400-164508400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
32	chr6:164507400-164508600	Enhancers	Brain Anterior Caudate	brain
33	chr6:164507400-164508800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
34	chr6:164507400-164508800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links